Iridium Holders Approve $54/Share Rocket Lab Merger at 99.6%

Iridium Communications stockholders adopted the company's merger agreement with Rocket Lab at a special meeting held 24 September 2026, with roughly 99.6% of votes cast in favor, the two companies announced. That support represented about 81.0% of Iridium's outstanding common shares entitled to vote. Under the deal, Iridium holders receive $27.00 in cash plus Rocket Lab stock at a collared exchange ratio for each Iridium share, a structure the companies put at a notional $54.00 per share. Completion is targeted for mid-2027.

Context — Why the Iridium Vote Matters Now

Shareholder approval is the step that converts a negotiated agreement into a transaction that can be taken to regulators. The report frames the vote as an important milestone toward completion, with the remaining gating items being required regulatory approvals and other customary closing conditions.

The companies gave no comparable vote tally from an earlier meeting or a prior proposal. What the report does supply is the sequence: the merger agreement was announced previously, a definitive proxy statement and final prospectus tied to the transaction was filed with the SEC on 26 August 2026, and the stockholder vote followed on 24 September. Full voting results will be reported in a Form 8-K.

That sequence explains the timing. Once a proxy is declared effective, the vote is the next scheduled event, and the outcome removes a deal-specific uncertainty rather than reflecting anything new about either business.

Neither company disclosed regulatory review timelines, the identity of reviewing jurisdictions, or the status of any filing in the report. The only date the report attaches is the mid-2027 completion target, which sits well beyond the vote itself.

For markets, the read-through is about deal certainty rather than operating results. A vote this lopsided reduces the probability that the transaction is derailed by a dissident holder bloc, shifting the remaining risk onto the regulatory calendar the report does not detail.

Data — What the Numbers Show

The vote count is the hard number. About 99.6% of votes cast favored adoption, and those votes equaled roughly 81.0% of all Iridium shares entitled to vote. The gap between those two percentages is the abstention and non-vote block, which the report does not break out.

Consideration is two-part. Iridium holders get $27.00 in cash per share, plus Rocket Lab common stock at a number of shares set by an exchange ratio, subject to a collar. The companies place the combined notional value at $54.00 per Iridium share.

Item	Detail
Votes cast in favor	~99.6%
Share of shares outstanding represented	~81.0%
Cash component	$27.00 per share
Stock component	Rocket Lab shares at collared exchange ratio
Notional value	$54.00 per Iridium share
Targeted completion	Mid-2027

The report gives no Rocket Lab market capitalization, no Iridium market capitalization, no exchange ratio figure, and no collar band, so the equity split of the $54.00 notional cannot be derived from the disclosed material. It also supplies no revenue, EBITDA, subscriber, or constellation-size figures for either company. The comparison available is structural: cash is fixed at $27.00, while the stock leg floats with Rocket Lab's share price inside the collar.

Analysis — What It Means for Markets and Tickers

The structure splits the economics between two tickers in a way that matters for holders. Iridium holders are long a fixed $27.00 cash floor plus a variable Rocket Lab equity stub, which means their realized value depends on where RKLB trades at closing, subject to the collar's limits. Rocket Lab holders carry the dilution from issuing the stock leg and the integration of Iridium's network, spectrum, and operating base.

Second-order exposure runs through the satellite and space value chain. The report describes Iridium as the operator of a global mobile satellite network with voice, data, messaging, PNT, and aircraft surveillance services, plus the Aireon space-based air traffic surveillance system, and a direct-to-device effort. Rocket Lab is described as a launch and space systems provider with the Electron rocket, the HASTE hypersonic test vehicle, the Neutron medium-lift vehicle in development, and spacecraft and components across more than 1,700 missions. A combined entity would span launch, components, and an operating constellation, a footprint that touches satellite operators, launch providers, and component suppliers generally.

The counter-argument is that approval was never the binding constraint. The report's own risk list leads with completion timing and regulatory approvals, and explicitly flags financing risk for the transaction. A near-unanimous vote does not shorten a regulatory review, and the mid-2027 target leaves a long window in which conditions could change.

Positioning follows the cash certainty. Event-driven holders of Iridium are now exposed mainly to the spread between the $54.00 notional consideration and where the stock trades, plus the collar's behavior on the Rocket Lab leg. Flow into the pair is likely to track regulatory headlines rather than either company's quarterly results.

Outlook — What to Watch Next

The Form 8-K with complete voting results is the first scheduled item, and it will show the precise vote and share counts behind the rounded figures in the announcement. The companies said they will file it with the SEC.

Regulatory approvals are the decisive catalyst. The report does not name jurisdictions, filing dates, or expected review periods, so the milestone to watch is any disclosed clearance or extension rather than a date.

The closing mechanics are the third item. Investors will need the exchange ratio, the collar band, and the closing share count to value the equity leg; the report provides none of these, and they should appear in transaction documents or subsequent filings. The mid-2027 completion target is the only date the companies gave, and it remains subject to approvals and customary conditions.

Frequently Asked Questions

What does the Iridium shareholder vote mean for retail investors?

It confirms holders adopted the merger agreement, moving the deal to the regulatory stage. Retail holders of Iridium are now positioned for $27.00 in cash plus Rocket Lab shares at a collared ratio if the transaction closes, a notional $54.00 per share. The value they ultimately receive depends on Rocket Lab's stock price at closing and on the collar's terms, which the announcement did not disclose. The cash portion is fixed.

What happens next for the Rocket Lab and Iridium transaction?

Iridium will file a Form 8-K with complete voting results. The companies then need the remaining required regulatory approvals and satisfaction of other customary closing conditions, with completion targeted for mid-2027. The announcement does not identify which regulators are reviewing the deal, whether any filings are pending, or what financing arrangements exist, so the next observable steps are filings and any clearance announcements.

Why is the cash-and-stock structure important?

The $27.00 cash component gives Iridium holders a fixed floor per share, while the Rocket Lab stock component floats with RKLB's price, bounded by a collar. That collar limits how much the equity leg can rise or fall relative to the agreed ratio. Because the announcement omits the exchange ratio and collar band, holders cannot yet calculate their exact share count, making the ratio a key detail to watch.

Bottom Line

Iridium holders approved the Rocket Lab merger with 99.6% of votes cast, leaving regulatory clearance and mid-2027 closing as the remaining hurdles.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.